Elevance Health Corporate & Other — Benefit expense increased by 200.0% to $9.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.0%, from $10.00M to $9.00M. Over 3 years (FY 2022 to FY 2025), Corporate & Other — Benefit expense shows a downward trend with a -13.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to premiums suggests deteriorating underwriting margins in non-core segments, while a decrease suggests improved claims management.
This metric represents the medical benefit expenses incurred by the corporate segment, typically associated with legacy...
Similar to 'medical loss ratio' components or 'benefit costs' in the corporate segments of major health insurers.
elv_segment_corporate_other_benefit_expense| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.75M | $9.75M | $9.75M | $9.75M | $8.75M | $8.75M | $8.75M | $8.75M | $10.00M | $0.00 | $5.00M | $4.00M | $10.00M | $8.00M | $4.00M | $3.00M | $9.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -10.3% | +0.0% | +0.0% | +0.0% | +14.3% | -100.0% | — | -20.0% | +150.0% | -20.0% | -50.0% | -25.0% | +200.0% |
| YoY Change | — | — | — | — | -10.3% | -10.3% | -10.3% | -10.3% | +14.3% | -100.0% | -42.9% | -54.3% | +0.0% | — | -20.0% | -25.0% | -10.0% |